Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
To access this article, please choose from the options below
PII: S0168-8278(10)00079-6
doi:10.1016/j.jhep.2010.01.025
© 2010 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
